Affymax plunges 85% on recall of anemia drug

Shares of Affymax plummet after the company recalls an anemia drug that caused several fatalities.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.